Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Jun;40(6):726–730. doi: 10.1136/gut.40.6.726

Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

H Miyaji 1, S Ito 1, T Azuma 1, Y Ito 1, Y Yamazaki 1, Y Ohtaki 1, F Sato 1, M Hirai 1, M Kuriyama 1, Y Kohli 1
PMCID: PMC1027196  PMID: 9245925

Abstract

BACKGROUND AND AIMS: Helicobacter pylori has strong urease activity. Ammonia produced by H pylori in the stomach can be a source of systemic ammonia in patients with hepatic dysfunction. The effect of the eradication of H pylori on hyperammonaemia was examined in patients with liver cirrhosis. SUBJECTS AND METHODS: Ammonia concentrations in blood and gastric juice were analysed in 50 patients with liver cirrhosis and hyperammonaemia. All patients were first treated with a low protein diet, kanamycin, lactulose, and branched chain enriched amino acid solution. Hyperammonaemia remained in 18 patients. These 18 patients were divided into three groups according to the status of H pylori infection; those with a diffuse distribution of H pylori in the stomach (group I), those with a regional distribution (group II), and those without H pylori (group III). These patients were given 30 mg iansoprazole, 1000 mg amoxicillin, and 400 mg clarithromycin or 500 mg metronidazole for two weeks to eradicate H pylori. RESULTS: In group I ammonia concentrations in blood and gastric juice were significantly reduced after H pylori eradication. The blood ammonia concentration at 12 weeks after the eradication was still significantly lower than that before eradication. In groups II and III the ammonia concentrations in blood and gastric juice were not significantly reduced after eradication therapy. CONCLUSIONS: The diffuse distribution of H-pylori in the stomach contributes partly to hyperammonaemia in patients with liver cirrhosis, and the eradication of H pylori is effective in patients with hyperammonaemia with diffuse H pylori infection in the stomach.

Full text

PDF
726

Images in this article

728Image
on p.728

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander T., Thomas K., Cherian A. M., Kanakasabapathy Effect of three antibacterial drugs in lowering blood & stool ammonia production in hepatic encephalopathy. Indian J Med Res. 1992 Oct;96:292–296. [PubMed] [Google Scholar]
  2. Bircher J., Müller J., Guggenheim P., Haemmerli U. P. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966 Apr 23;1(7443):890–892. doi: 10.1016/s0140-6736(66)91573-x. [DOI] [PubMed] [Google Scholar]
  3. Blaser M. J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 1990 Apr;161(4):626–633. doi: 10.1093/infdis/161.4.626. [DOI] [PubMed] [Google Scholar]
  4. Blaser M. J., Kobayashi K., Cover T. L., Cao P., Feurer I. D., Pérez-Pérez G. I. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer. 1993 Nov 11;55(5):799–802. doi: 10.1002/ijc.2910550518. [DOI] [PubMed] [Google Scholar]
  5. Blei A. T., Olafsson S., Therrien G., Butterworth R. F. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology. 1994 Jun;19(6):1437–1444. [PubMed] [Google Scholar]
  6. Capocaccia L., Riggio O. Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other? Hepatology. 1990 Aug;12(2):368–370. doi: 10.1002/hep.1840120228. [DOI] [PubMed] [Google Scholar]
  7. Dunn B. E., Campbell G. P., Perez-Perez G. I., Blaser M. J. Purification and characterization of urease from Helicobacter pylori. J Biol Chem. 1990 Jun 5;265(16):9464–9469. [PubMed] [Google Scholar]
  8. Elkington S. G., Floch M. H., Conn H. O. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med. 1969 Aug 21;281(8):408–412. doi: 10.1056/NEJM196908212810803. [DOI] [PubMed] [Google Scholar]
  9. Felipo V., Miñana M. D., Grisolía S. Paradoxical protection of both protein-free and high protein diets against acute ammonium intoxication. Biochem Biophys Res Commun. 1988 Oct 14;156(1):506–510. doi: 10.1016/s0006-291x(88)80870-2. [DOI] [PubMed] [Google Scholar]
  10. Fischer J. E., Funovics J. M., Aguirre A., James J. H., Keane J. M., Wesdorp R. I., Yoshimura N., Westman T. The role of plasma amino acids in hepatic encephalopathy. Surgery. 1975 Sep;78(3):276–290. [PubMed] [Google Scholar]
  11. Forbes G. M., Glaser M. E., Cullen D. J., Warren J. R., Christiansen K. J., Marshall B. J., Collins B. J. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet. 1994 Jan 29;343(8892):258–260. doi: 10.1016/s0140-6736(94)91111-8. [DOI] [PubMed] [Google Scholar]
  12. Higuchi K., Shimizu Y., Nambu S., Miyabayashi C., Takahara T., Saito S., Hioki O., Kuwabara Y., Watanabe A. Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalopathy. J Gastroenterol Hepatol. 1994 Jul-Aug;9(4):366–372. doi: 10.1111/j.1440-1746.1994.tb01257.x. [DOI] [PubMed] [Google Scholar]
  13. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  14. Ito S., Miyaji H., Azuma T., Li Y., Ito Y., Kato T., Kohli Y., Kuriyama M. Hyperammonaemia and Helicobacter pylori. Lancet. 1995 Jul 8;346(8967):124–125. doi: 10.1016/s0140-6736(95)92147-8. [DOI] [PubMed] [Google Scholar]
  15. Johnston B. J., Reed P. I., Ali M. H. Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut. 1986 Oct;27(10):1132–1137. doi: 10.1136/gut.27.10.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Labenz J., Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 1994;55(1):19–23. doi: 10.1159/000201117. [DOI] [PubMed] [Google Scholar]
  17. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  18. Miyaji H., Kohli Y., Azuma T., Ito S., Hirai M., Ito Y., Kato T., Kuriyama M. Endoscopic cross-infection with Helicobacter pylori. Lancet. 1995 Feb 18;345(8947):464–464. [PubMed] [Google Scholar]
  19. Mortensen P. B. The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion. Hepatology. 1992 Dec;16(6):1350–1356. doi: 10.1002/hep.1840160608. [DOI] [PubMed] [Google Scholar]
  20. Nomura A., Stemmermann G. N., Chyou P. H., Kato I., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991 Oct 17;325(16):1132–1136. doi: 10.1056/NEJM199110173251604. [DOI] [PubMed] [Google Scholar]
  21. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  22. Parsonnet J., Hansen S., Rodriguez L., Gelb A. B., Warnke R. A., Jellum E., Orentreich N., Vogelman J. H., Friedman G. D. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994 May 5;330(18):1267–1271. doi: 10.1056/NEJM199405053301803. [DOI] [PubMed] [Google Scholar]
  23. Pirotte J., Guffens J. M., Devos J. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose. Digestion. 1974;10(6):435–444. doi: 10.1159/000197556. [DOI] [PubMed] [Google Scholar]
  24. Plevris J. N., Morgenstern R., Hayes P. C., Bouchier I. A. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet. 1995 Oct 21;346(8982):1104–1104. doi: 10.1016/s0140-6736(95)91780-2. [DOI] [PubMed] [Google Scholar]
  25. Pérez-Pérez G. I., Gower C. B., Blaser M. J. Effects of cations on Helicobacter pylori urease activity, release, and stability. Infect Immun. 1994 Jan;62(1):299–302. doi: 10.1128/iai.62.1.299-302.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Quero J. C., Hartmann I. J., de Rooij F., Wilson J. H., Schalm S. W. Hyperammonaemia and Helicobacter pylori. Lancet. 1995 Sep 9;346(8976):713–714. doi: 10.1016/s0140-6736(95)92332-2. [DOI] [PubMed] [Google Scholar]
  27. Sung J. J., Chung S. C., Ling T. K., Yung M. Y., Leung V. K., Ng E. K., Li M. K., Cheng A. F., Li A. K. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med. 1995 Jan 19;332(3):139–142. doi: 10.1056/NEJM199501193320302. [DOI] [PubMed] [Google Scholar]
  28. Talley N. J., Zinsmeister A. R., Weaver A., DiMagno E. P., Carpenter H. A., Perez-Perez G. I., Blaser M. J. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4;83(23):1734–1739. doi: 10.1093/jnci/83.23.1734. [DOI] [PubMed] [Google Scholar]
  29. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  30. Van Thiel D. H., Fagiuoli S., Wright H. I., Chien M. C., Gavaler J. S. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology. 1994 Jan;19(1):67–71. [PubMed] [Google Scholar]
  31. Voorhies T. M., Ehrlich M. E., Duffy T. E., Petito C. K., Plum F. Acute hyperammonemia in the young primate: physiologic and neuropathologic correlates. Pediatr Res. 1983 Dec;17(12):970–975. doi: 10.1203/00006450-198312000-00009. [DOI] [PubMed] [Google Scholar]
  32. Wapnick S., Guinto R., Reizis I., LeVeen H. H. Reduction of postoperative infection in elective colon surgery with preoperative administration of kanamycin and erythromycin. Surgery. 1979 Mar;85(3):317–321. [PubMed] [Google Scholar]
  33. Weber F. L., Jr, Bagby B. S., Licate L., Kelsen S. G. Effects of branched-chain amino acids on nitrogen metabolism in patients with cirrhosis. Hepatology. 1990 Jun;11(6):942–950. doi: 10.1002/hep.1840110606. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES